<DOC>
	<DOC>NCT00564499</DOC>
	<brief_summary>A Scientific Research Program to evaluate the efficacy of SYMBICORT® 320/9μg in the treatment of COPD in real life environment by General Practitioners</brief_summary>
	<brief_title>SYMBICORT® in the Treatment of COPD</brief_title>
	<detailed_description />
	<mesh_term>Budesonide, Formoterol Fumarate Drug Combination</mesh_term>
	<criteria>patients (m/f) with COPD (GOLD stadium III and IV) patients who recently quit smoking (&lt;3months)</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>January 2011</verification_date>
	<keyword>COPD</keyword>
	<keyword>Symbicort</keyword>
	<keyword>General Practitioners</keyword>
</DOC>